The omega-3 I recommend to my patients is mercury-free, pharmaceutical grade and free from aftertaste. Please use our patient discount code, KidzVision10 at www.prnomegahealth.com. Enter the discount code at the bottom of the page upon checkout.
Institute of Psychiatry, King's College London. email@example.com
3-9% of schoolchildren in the U.K. suffer Attention Deficit and Hyperactivity Disorder (ADHD). Since the 1950s stimulants have been used. particularly methylphenidate and dextroamphetamine, with some 75% response rate. The first non-stimulant medication--atmoxetine hydrochloride, has also been used. However, side effects have included: growth retardation; appetite loss: headache: stomachache: heart problem: insomnia: seizure; change of character: addiction or even suicidal thoughts. Alternative treatments have been used including omega-3s, yet the way they benefit in ADHD is uncertain. They may be important in remodelling dendrites and synapses, and/or sustaining: blood brain barrier, neuronal membrane. neurotransmitter channel, receptors and ion channel. Stevens in 2003 found long-chain polyunsaturated fatty acids (LCPUFAs) effective for oppositional defiant disorder, whereas Eicosapentaenoic acid (EPA) specifically was helpful with disruptive behaviour. Docosahexaenoic acid (DHA) is important during gestation and early infancy, particularly for neurodevelopment. The Durham Trial by Richardson published in 2005, tested omega-3s with omega-6s on schoolchildren with developmental coordination disorder (many of them had ADHD symptoms), improving scores in co-ordination and short term memory.
PMID: 18309764 [PubMed - indexed for MEDLINE]
J Med Food. 2007 Dec;10(4):662-6.
A 5-month open study with long-chain polyunsaturated fatty acids in dyslexia.Lindmark L, Clough P.
Falsterbo, Sweden. firstname.lastname@example.org
This open pilot study investigated effects of a docosahexaenoic acid (DHA)-rich supplement on learning ability in a group of 20 dyslexic children in Sweden. Children formally diagnosed as dyslexic took eight capsules per day of a long-chain polyunsaturated fatty acid (LC-PUFA) supplement containing high-DHA fish oil and evening primrose oil. Subjective assessments by the children and their parents were completed at baseline and 6, 12, and 20 weeks after supplementation. Quantitative evaluation by word-chain test was completed before and after 4 months of supplementation to measure word decoding (speed of reading) and letter decoding (motoric-perceptual speed). Subjective parent and child assessments showed increasing numbers of positive responders over time in reading speed, general schoolwork, and overall perceived benefit. Significant improvements were observed in reading speed and motor-perceptual velocity. Thirteen of 17 children had a significant improvement on the word-chain test (P < .04). Reading speed improved by 60% from 1.76 +/- 0.29 before the study to 2.82 +/- 0.36 after supplementation (P < .01 by Wilcoxon sign test). Motoric-perceptual velocity improved by 23% from a stanine value of 3.76 +/- 0.42 to 4.65 +/- 0.66 after supplementation (P < .05 by Wilcoxon sign test). Thus LC-PUFA supplementation for 5 months provides positive and clear beneficial effect on variables usually impaired by dyslexia.
Nutr Health. 2006;18(3):233-47
The role of dietary fatty acids in children's behaviour and learning.Portwood MM.
Educational Psychology Service, DCC Education Development Centre, Co Durham, DL16 6YP, UK. email@example.com
A growing awareness and understanding of the profiles of local children in County Durham, UK, experiencing learning and behavioural difficulties throughout the education system, has resulted in a number of school based nutritional intervention studies being undertaken. Evidence suggests that some children and young adults with developmental difficulties have a deficiency of particular omega 3 and omega 6 polyunsaturated fatty acids and supplementation with these nutrients can have an impact on their behaviour, concentration and performance on standardised assessments. The first randomised placebo controlled trial to be carried out on children in Durham with developmental coordination disorder has demonstrated significant effects of fatty acid supplementation on behaviour, reading and spelling performance. We are conducting further scientific studies within Durham and neighbouring Authorities in the North of England to be published at a future time. We have also carried out a number of open label treatment studies within schools to help us understand better the role that nutritional intervention can play across a broader range of age groups and abilities. The results suggest positive outcomes for a substantial proportion of children who are more able to engage with the educational opportunities presented to them. This is an important finding to be shared with educationalists, health professionals and importantly the parents.
www.prnomegahealth.com, Discount Code, KidzVision10